Undertreatment of PAD: Preventive Management and Treatment Strategies-Developing a PAD Treatment Plan Including GDMT and Emerging Therapeutics: Undertreatment of PAD

Developing a PAD Treatment Plan Including GDMT and Emerging Therapeutics: Undertreatment of PAD

Video Transcription

Video Summary

In this video, Philip Goodney discusses the undertreatment of peripheral arterial disease (PAD) and the need for annual integrated preventive measures to limit the progression of the disease and improve patient outcomes. He highlights the significant variation in care for patients with PAD, as shown by the variation in amputation rates across different regions of the United States. Goodney emphasizes the importance of certain preventive measures, including hemoglobin A1C testing, diabetic foot care, and vascular assessment. However, he notes that the provision of these measures is limited and adherence is low, particularly among high-risk populations such as African American, Hispanic, and Native American patients. Goodney also discusses the need for patient-level and population-level pathways to improve the delivery of preventive measures. He concludes by emphasizing the importance of focusing these efforts on the most at-risk populations.

Keywords

peripheral arterial disease

undertreatment

amputation rates

preventive measures

high-risk populations

delivery of preventive measures